Clinical Trial Update: Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tildrakizumab for nail psoriasis in chronic plaque psoriasis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nail Psoriasis
• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Chronic Plaque Psoriasis, Moderate to Severe Nail Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2025-06-06